Dataset Information

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

ABSTRACT: Gray platelet syndrome (GPS) is a rare recessive disorder caused by biallelic variants in NBEAL2 and characterized by bleeding symptoms, the absence of platelet α-granules, splenomegaly, and bone marrow (BM) fibrosis. Due to the rarity of GPS, it has been difficult to fully understand the pathogenic processes that lead to these clinical sequelae. To discern the spectrum of pathologic features, we performed a detailed clinical genotypic and phenotypic study of 47 patients with GPS and identified 32 new etiologic variants in NBEAL2. The GPS patient cohort exhibited known phenotypes, including macrothrombocytopenia, BM fibrosis, megakaryocyte emperipolesis of neutrophils, splenomegaly, and elevated serum vitamin B12 levels. Novel clinical phenotypes were also observed, including reduced leukocyte counts and increased presence of autoimmune disease and positive autoantibodies. There were widespread differences in the transcriptome and proteome of GPS platelets, neutrophils, monocytes, and CD4 lymphocytes. Proteins less abundant in these cells were enriched for constituents of granules, supporting a role for Nbeal2 in the function of these organelles across a wide range of blood cells. Proteomic analysis of GPS plasma showed increased levels of proteins associated with inflammation and immune response. One-quarter of plasma proteins increased in GPS are known to be synthesized outside of hematopoietic cells, predominantly in the liver. In summary, our data show that, in addition to the well-described platelet defects in GPS, there are immune defects. The abnormal immune cells may be the drivers of systemic abnormalities such as autoimmune disease.

SUBMITTER: Sims MC

PROVIDER: S-EPMC7582559 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

Sims Matthew C MC Mayer Louisa L Collins Janine H JH Bariana Tadbir K TK Megy Karyn K Lavenu-Bombled Cecile C Seyres Denis D Kollipara Laxmikanth L Burden Frances S FS Greene Daniel D Lee Dave D Rodriguez-Romera Antonio A Alessi Marie-Christine MC Astle William J WJ Bahou Wadie F WF Bury Loredana L Chalmers Elizabeth E Da Silva Rachael R De Candia Erica E Deevi Sri V V SVV Farrow Samantha S Gomez Keith K Grassi Luigi L Greinacher Andreas A Gresele Paolo P Hart Dan D Hurtaud Marie-Françoise MF Kelly Anne M AM Kerr Ron R Le Quellec Sandra S Leblanc Thierry T Leinøe Eva B EB Mapeta Rutendo R McKinney Harriet H Michelson Alan D AD Morais Sara S Nugent Diane D Papadia Sofia S Park Soo J SJ Pasi John J Podda Gian Marco GM Poon Man-Chiu MC Reed Rachel R Sekhar Mallika M Shalev Hanna H Sivapalaratnam Suthesh S Steinberg-Shemer Orna O Stephens Jonathan C JC Tait Robert C RC Turro Ernest E Wu John K M JKM Zieger Barbara B Kuijpers Taco W TW Whetton Anthony D AD Sickmann Albert A Freson Kathleen K Downes Kate K Erber Wendy N WN Frontini Mattia M Nurden Paquita P Ouwehand Willem H WH Favier Remi R Guerrero Jose A JA

Blood 20201001 17

Gray platelet syndrome (GPS) is a rare recessive disorder caused by biallelic variants in NBEAL2 and characterized by bleeding symptoms, the absence of platelet α-granules, splenomegaly, and bone marrow (BM) fibrosis. Due to the rarity of GPS, it has been difficult to fully understand the pathogenic processes that lead to these clinical sequelae. To discern the spectrum of pathologic features, we performed a detailed clinical genotypic and phenotypic study of 47 patients with GPS and identified ...[more]

PMID: 32693407

Similar Datasets

Project description:Essentials Platelet dense granule (DG) deficiency is a major abnormality in RUNX1 haplodeficiency patients. The molecular mechanisms leading to the platelet DG deficiency are unknown. Platelet expression of PLDN (BLOC1S6, pallidin), involved in DG biogenesis, is regulated by RUNX1. Downregulation of PLDN is a mechanism for DG deficiency in RUNX1 haplodeficiency.SummaryBackground Inherited RUNX1 haplodeficiency is associated with thrombocytopenia and platelet dysfunction. Dense granule (DG) deficiency has been reported in patients with RUNX1 haplodeficiency, but the molecular mechanisms are unknown. Platelet mRNA expression profiling in a patient previously reported by us with a RUNX1 mutation and platelet dysfunction showed decreased expression of PLDN (BLOC1S6), which encodes pallidin, a subunit of biogenesis of lysosome-related organelles complex-1 (BLOC-1) involved in DG biogenesis. PLDN mutations in the pallid mouse and Hermansky-Pudlak syndrome-9 are associated with platelet DG deficiency. Objectives We postulated that PLDN is a RUNX1 target, and that its decreased expression leads to platelet DG deficiency in RUNX1 haplodeficiency. Results Platelet pallidin and DG levels were decreased in our patient. This was also observed in two siblings from a different family with a RUNX1 mutation. Chromatin immunoprecipitation and electrophoretic mobility shift assays with phorbol ester-treated human erythroleukemia (HEL) cells showed RUNX1 binding to RUNX1 consensus sites in the PLDN1 5' upstream region. In luciferase reporter studies, mutation of RUNX1 sites in the PLDN promoter reduced activity. RUNX1 overexpression enhanced and RUNX1 downregulation decreased PLDN1 promoter activity and protein expression. RUNX1 downregulation resulted in impaired handling of mepacrine and mislocalization of the DG marker CD63 in HEL cells, indicating impaired DG formation, recapitulating findings on PLDN downregulation. Conclusions These studies provide the first evidence that PLDN is a direct target of RUNX1 and that its dysregulation is a mechanism for platelet DG deficiency associated with RUNX1 haplodeficiency.

Dataset Information

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

Publications

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets